Health Status in Patients with COPD According to GOLD 2017 Classification: Use of the COMCOLD Score in Routine Clinical Practice

References

• Miravitlles M, Mario C, Guerrero T, Gisbert S. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest. 2003;123:784–791.
   PubMed Web of Science ®Google Scholar
• García-Olmos L, Alberquilla A, Ayala V, García-Sagredo P, Morales L, Carmona M, de Tena-Dávila MJ, Pascual M, Muñoz A, Salavdor CH, et al. Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study. BMC Fam Pract. 2013;14:11.
   PubMed Web of Science ®Google Scholar
• Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, et al. Impact of comorbidities on COPD-specific health-related quality of life. Respir Med. 2013;107:233–241.
   PubMed Web of Science ®Google Scholar
• Van Manen JG, Bindels PJ, IJzermans CJ, van der Zee JS, Bottema BJ, Schadé E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol. 2001;54:287–293.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Costi S, Luppi F, Cirelli G, Cilione C, Coletti O, Fabbri M, Clini EM. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63:487–492.
   PubMed Web of Science ®Google Scholar
• Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med. 2000;160:2653–2658.
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1:73–83.
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, Casanova C, Marín JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake1 G, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155–156.
   PubMed Web of Science ®Google Scholar
• Miller J, Edwards LD, Agustí A, Bakke P, Calverley PM, Celli B, Coxson HO, Krim C, Lomas DA, Miller BE, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107:1376–1384.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, Díaz-Manglano J, Mario C, Heredia JL. Short and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014;145:972–980.
   PubMed Web of Science ®Google Scholar
• Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Pérez T, Soler-Cataluña JJ, van Der Molen T, Adamek L, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011;105:57–66.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Casanova C, Hernández C, Abreu J, Montejo de Garcini A, Aguirre-Jaime A, Celli B. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes. 2006;4:72.
   PubMed Web of Science ®Google Scholar
• Balcells E, Gea J, Ferrer J, Serra I, Orozco-Levi M, de Batlle J, Rodriguez E, Benet M, Donaire-González D, Ante JM, et al. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes. 2010;8:108.
   PubMed Web of Science ®Google Scholar
• Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, Boyd CM, ter Riet G, Puhan MA. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67:904–911.
   PubMed Web of Science ®Google Scholar
• Lee H, Jhun BW, Cho J, Yoo KH, Lee JH, Kim DK, Lee JD, Jung KS, Lee JY, Park HY. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity. Int J Chron Obstruct Pulmon Dis. 2017;12:3301–3310.
   PubMed Web of Science ®Google Scholar
• Putcha N, Puhan MA, Hansel NN, Drummond MB, Boyd CM. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD. 2013;10:324–332.
   PubMedGoogle Scholar
• Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, Behr J, Wacker M, Biertz F, Watz H, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med. 2018;134:79–85
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management and prevention of COPD. Global initiative for chronic obstructive lung disease (GOLD); 2017. Available from: http://www.goldcopd.org.
   Google Scholar
• Pérez-Manchón D, Álvarez-García GM. Comprehensive assessment of chronic obstructive pulmonary disease in primary care. Quality of life and mortality associated comorbidity. Aten Primaria. 2017;49:255–256.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest.1988;93:580–586.
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD); 2009. Available from: http://www.goldcopd.org.
   Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648–654.
   PubMed Web of Science ®Google Scholar
• Zhang B, Bilder C, Biggerstaff B, Schaarschmidt F, Hitt B, binGroup. 2018: Evaluation and Experimental Design for Binomial Group Testing. R Package Version 2.1–1.
   Google Scholar
• Spilker B, Revicki DA. Taxonomy of quality of life. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincort-Raven; 1996. p. 25–31
   Google Scholar
• Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med.1997;156:1032–1039.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Kinne S, Engelberg RA, Pearlman RA. Functional status and perceived quality of life in adults with and without chronic conditions. J Clin Epidemiol. 2000;53:779–785.
   PubMed Web of Science ®Google Scholar
• de La Fuente Cid R, de La Iglesia Martínez F, Ramos Polledo V, Pellicer Vázquez C, Nicolás Miguel R, Diz-Lois Martínez F. Factor analysis of the health related quality of life of patients with stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2001;37:411–416.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Agusti A, Wouters EF, Bakke P, Calverley PM, Celli B, Coxson H, Crim C, Edwards D, Locantore N, et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med. 2014;189:1022–1030.
   PubMed Web of Science ®Google Scholar
• Ketekaars CAJ, Schlösser MAG, Mostert R, Huyer Abu-Saar H, Halfens RJG, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax. 1996;51:39–43.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Molina J, Naberan K, Cots JM, Ros F, Llor C; EVOCA study. Factors determining the quality of life of patients with COPD in primary care. Ther Adv Respir Dis. 2007;1:85–92.
   PubMedGoogle Scholar
• Shavro SA, Ezhilarasu P, Augustine J, Bechtel JJ, Christopher DJ. Correlation of health-related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2012;7:291–296.
   PubMed Web of Science ®Google Scholar
• Reardon JZ, Lareau SC, ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119(10 suppl 1):32–37.
   PubMed Web of Science ®Google Scholar
• Monteagudo M, Rodriguez Blanco T, Llagostera M, Valoro C, Bayona X, Ferrer M, Miravitlles M. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013;107:1589–1597.
   PubMed Web of Science ®Google Scholar
• Jones PW, Brusselle G, Dal Negro RW. Patient-centred assessment of COPD in primary care: experience from cross sectional study of health-related quality of life in Europe. Prim Care Respir J. 2012;21:329–336.
   PubMedGoogle Scholar
• Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved COPD specific version of the St. George Respiratory Questionnaire. Chest. 2007;132:456–463.
   PubMed Web of Science ®Google Scholar
• Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167:60e7.
   Google Scholar
• Patel ARC, Donaldson GC, Mackay AJ, Wedzicha JA, Hurst JR. The impact of ischemic heart disease on symptoms, health status, and exacerbations inpatients with COPD. Chest. 2012;141:851–857
   PubMed Web of Science ®Google Scholar
• González-Gutiérrez MV, Guerrero Velázquez J, Morales García C, Casas Maldonado F, Gómez Jiménez FJ, González Vargas F. Predictive model for anxiety and depression in Spanish patients with stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2016;52:151–157.
   PubMed Web of Science ®Google Scholar
• Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100:1767–774.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Molina J, Quintano JA, Campuzano A, Perez J, Roncero C. Factors associated with depression and severe depression in patients with COPD. Respir Med. 2014;108:1615–1625.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D. Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study. Int J Chron Obstruct Pulmon Dis. 2017;12:339–349.
   PubMed Web of Science ®Google Scholar
• García-Rio F, Soriano JB, Miravitlles M, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One. 2014;9:e105220.
   PubMed Web of Science ®Google Scholar
• Lambert AA, Putcha N, Drummond MB, Boriek AM, Hanania NA, Kim V, Kinney GL, McDonald MN, Brigham EP, Wise RA, et al. Obesity is associated with increased morbidity in moderate to severe COPD. Chest. 2017;151:68–77.
   PubMed Web of Science ®Google Scholar
• von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011;140:730–736.
   PubMed Web of Science ®Google Scholar
• Han J, Dai L, Zhong N, Young D. Breathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitions. COPD. 2015;12:115–125.
   PubMedGoogle Scholar
• Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, Lammers JW, Zanen P, Hoes AW, Störk S, et al. "GOLD or lower limit of normal definition? a comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study”. Respir Res. 2012;13:13.
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63:1046–1051.
   PubMed Web of Science ®Google Scholar
• Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest. 2007;131:349–355.
   PubMed Web of Science ®Google Scholar
• Schermer TR, Smeele IJ, Thoonen BP, Lucas AE, Grootens JG, van Boxem TJ, Heijdra YF, van Weel C. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J. 2008;32:945–952.
   PubMed Web of Science ®Google Scholar